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Abstract Several components of translation, e.g. eIF4E and
PKR, are implicated in cancer. The e-subunit (p48) of
mammalian initiation factor 3 is encoded by the Int6 gene, a
common site for integration of the mouse mammary tumor virus
genome, leading to the production of a truncated eukaryotic
initiation factor-3e (eIF3e). Stable expression of a truncated
eIF3e in NIH 3T3 cells causes malignant transformation by four
criteria: foci formation; anchorage independent growth; accel-
erated growth; and lack of contact inhibition. Stable expression
of full-length eIF3e does not cause transformation. The truncated
eIF3e also inhibits the onset of apoptosis caused by serum
starvation. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Much evidence supports the idea that protein synthesis is
involved in the regulation of cell proliferation, and that its
dysregulation contributes to the loss of cell cycle control [1].
Mutations in genes that a¡ect translational control may be
oncogenic. Translation is also a target of signal transduction
pathways; perturbations within these pathways may a¡ect
translational components that contribute to the malignant
state of the cell. Two well-studied examples are eIF4E and
PKR. eIF4E is the m7GTP cap binding initiation factor in
the eIF4F complex. Lazaris-Karatzas and coworkers [2]
showed that overexpression of eIF4E in NIH 3T3 cells results
in transformation and activation of the ras oncogene. Sup-
pression of eIF4E activity in transformed cells by overexpres-
sion of the eIF4E binding proteins 4E-BP1 or 4E-BP2 results
in partial reversal of the transformed phenotype [3]. Elevated
eIF4E levels prevent apoptosis in NIH 3T3 cells subjected to
serum starvation [4], whereas overexpression of 4E-BP1 or
rapamycin treatment increases the susceptibility to apoptosis
[5]. Thus, failure to down-regulate eIF4E may result in loss of
growth control. It is noteworthy that overexpression of eIF4E
mRNA or protein has been observed in a wide variety of
transformed cell lines and solid tumors [6].
Overexpression of a dominant negative mutant form of the
eukaryotic initiation factor-2K (eIF2K) kinase, PKR, causes
malignant transformation of NIH 3T3 cells [7]. Overexpres-
sion of TRBP [8] or p58 [9], inhibitors of PKR, also causes
malignancy. This suggests that PKR may act as a tumor sup-
pressor through its down-regulation of protein synthesis by
eIF2K phosphorylation. However, the issue is clouded by
the fact that PKR has targets outside of translation. The
problem was addressed by overexpression of eIF2K and an
eIF2K mutant form where its phosphorylation site, Ser-51,
was substituted by Ala [10]. Cells transformed with the mu-
tant form became malignant whereas cells overexpressing the
wild type factor did not. As with overexpressed eIF4E, the
failure to down-regulate translation appears to contribute to
dysregulation of cell proliferation. An apparent contradiction
to the involvement of eIF2K phosphorylation is the elevated
level of PKR found in some cancers [11,12]. Lower levels of
PKR in cancer cells would be expected if PKR acts as a tumor
suppressor. Also arguing against a role for PKR in cancer is
the ¢nding that the PKR double knockout mouse shows no
predisposition to cancer [13]. However, in this case, eIF2
phosphorylation may occur through the action of other
eIF2 kinases.
Another translation initiation factor implicated in cancer is
eIF3. eIF3 is a high molecular weight complex of 11 or more
protein subunits that plays an important role in the initiation
pathway. The factor helps dissociate 80S ribosomes into ribo-
somal subunits ; it promotes the binding of Met-tRNAi and
mRNA to the 40S subunit ; and it binds directly to eIF1 [14],
eIF4B [15], eIF4G [16] and eIF5 [17], perhaps playing an
organizational role on the surface of the ribosome. The
eIF3 a-subunit (p170) is present at high levels in human mam-
mary carcinomas and esophageal squamous cell carcinomas
[18]. Furthermore, a yeast strain expressing a mutant form of
TIF32, encoding the homolog of human eIF3a, is blocked at
the G1 phase of the cell cycle [19]. Finally, overexpression of
eIF3h (p40) occurs in some human breast and prostate can-
cers [20].
The eIF3 e-subunit (p48) also has been implicated in the
regulation of cell proliferation. eIF3e is encoded by Int6, a
common site of integration for the mouse mammary tumor
virus (MMTV) [21]. Viral genome integration occurs within
introns of Int6, in opposite translation orientation to Int6,
resulting in truncation of Int6 by an in-frame stop codon
within the viral long terminal repeat (LTR) [22]. Int6 is con-
served throughout evolution with homologous sequences in
Drosophila, Caenorhabditis elegans, budding and ¢ssion yeast,
mice, and humans [23]. The eIF3e homolog in Arabidopsis has
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been shown to interact directly with the eIF3c (p110) homolog
and the COP9 signalosome [24]. The eIF3e homolog is not
essential for growth in budding [25] nor ¢ssion [26] yeast and
vint6 strains show only moderate inhibition of protein syn-
thesis and no change in polysome pro¢les. Yeast eIF3e has
been localized to the cytoplasm of cells by both in vitro and in
vivo methods [27]. Flag-tagged eIF3e overexpressed in COS-7
cells localizes to the nucleus; however, overexpression of the
Tax oncoprotein of the human T-cell leukemia virus causes
eIF3e to appear in the cytoplasm [28]. Guo and Sen [29] later
showed that the clone used to show nuclear localization
lacked the nine amino-terminal amino acids required for ex-
port. More speci¢cally, eIF3e has been seen associated with
the Golgi apparatus, although no post-translational modi¢ca-
tion of eIF3e has been observed. The Int6 gene has been
localized to human chromosome region 8q22-q23, a 45 kb
region containing 13 exons. Int6 also has been implicated in
human cancers: 28% of primary human breast carcinomas
exibit a loss of heterozygosity (LOH) [30]. Another study
revealed that 37% of primary human breast tumors and
31% of non-small cell lung carcinomas have reduced Int6
mRNA expression [31]. In addition to eIF3e’s interaction
with the Tax oncoprotein cited above, eIF3e has been shown
to interact with the interferon-induced protein p56 [29]. Inter-
action of eIF3e with the interferon system strengthens the idea
that eIF3e is involved in regulation of translation. Guo and
Sen also showed that the interaction of eIF3e with p56 inhib-
its translation [32].
The ¢ndings above suggest that eIF3e is important in the
regulation of cell proliferation. The role of the e-subunit in
eIF3 and in translation initiation is not known. The conse-
quences of expressing a severely truncated form of eIF3e, such
as occurs in the MMTV genome insertions into Int6, also have
not been described. We therefore have constructed long-term
transfected NIH 3T3 cell lines that express either the full-
length or truncated forms of eIF3e. We show that expression
of truncated eIF3e is su⁄cient to cause the malignant trans-
formation of NIH 3T3 cells.
2. Materials and methods
2.1. Construction of pMV7:p48 and pMV7:p48T
DNA encoding full-length eIF3e was ampli¢ed from pTZp48 [33]
by PCR with custom primers to give a full-length product, or a prod-
uct truncated after exon 4 (amino acid 157). The primers incorporated
a 5P EcoRI site and 3P HindIII site for cloning into the EcoRI and
HindIII sites of pMV7 [34] to yield pMV7:p48 and pMV7:p48T re-
spectively.
2.2. Stable expression of eIF3e and truncated eIF3e
Stable cell lines were produced following the methods of Kirschmei-
er et al. [34]. Brie£y, 82P cells were transfected with XhoI-linearized
pMV7:p48 and pMV7:p48T using the calcium phosphate method,
followed by selection with G418 for 10 days. The virus containing
supernatant was used to infect NIH 3T3 cells. Viral-infected cells
were grown in G418 selection media until colonies were of suitable
size to select (10^14 days). 24 colonies were selected from the
pMV7:p48T cells and identi¢ed as p48T1-24 and the remainder
were pooled and identi¢ed as p48TP. The pMV7:p48 cells were
pooled and identi¢ed as p48P.
2.3. Northern blot analysis
PolyA mRNA was isolated following the protocol provided by the
Oligotex mRNA Direct kit (Qiagen). RNA (2 Wg) was run on a 1.2%
denaturing agarose gel and transferred to nitrocellulose. The blot was
probed with a 32P-labeled eIF3e probe and a neomycin probe follow-
ing the protocol provided with the Random Prime kit (LifeTech) and
Northern Hybridization Solution (Stratagene).
2.4. Growth rate and foci formation
The long-term transfected cells (1U105) were plated on 35 mm
plates. Cells were fed every other day with Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS)
and were counted every 24 h with a hemocytometer. For foci forma-
tion, cells were grown 7 days past con£uence and stained with 0.1%
methylene blue and photographed.
2.5. Anchorage independent growth
5U104 cells in 0.35% agar containing 20% FCS were overlaid onto
0.5% agar in a 35 mm plate. Two days post plating, 2 ml of 20%
FCS^DMEM was added. Colonies were photographed 3 weeks after
plating.
2.6. Apoptosis assay
Cells were cultured on chamber slides under normal growth con-
ditions until 80% con£uent, then cells were cultured for 48 h in
DMEM lacking serum. Cells were ¢xed, permeabilized, and stained
with 0.1 Wg/ml TRITC-labeled Phalloidin and 2 Wg/ml DAPI. Cells
were observed with a £uorescent microscope and the appropriate ¢lter
sets. Apoptosis is indicated by chromatin condensation, resulting is
smaller more intense nuclear staining.
3. Results
NIH 3T3 cell lines stably expressing eIF3e (called p48P)
and a truncated version of eIF3e (called p48T) were con-
structed as described in Section 2. All p48T clones were char-
acterized, and an extensive study is reported for two of the
cloned cell lines, p48T1 and p48T2.
Cell lines from pooled clones were examined for the expres-
sion of eIF3e (p48P) and truncated eIF3e (p48TP) mRNAs as
described in Section 2. Fig. 1 shows the Northern blot of
control 3T3 cells along with p48T1, p48T2, p48TP and the
full-length p48P probed with a fragment of eIF3e cDNA. In
Fig. 1. Northern blot analysis of eIF3e transcripts. Poly(A) RNA
from each cell line was prepared and subjected to Northern blot
analysis as described in Section 2. The blot was treated with an
eIF3e probe and a Neo probe and exposed to an X-ray ¢lm. RNA
size markers are indicated on the left.
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the wild type 3T3 lanes hybridization of the probes is not
observed; however, after longer exposures of the eIF3e-
probed membrane, a faint band slightly smaller than the
1.35 kb marker is seen, indicating the endogenous mRNA
(data not shown). The cells stably expressing full-length and
truncated eIF3e react strongly with both the eIF3e probe and
the Neo probe. The larger than expected bands are due to
incorporation of the viral LTRs and Neo into the mRNA
[34]. Given the high mRNA expression, we attempted to dem-
onstrate enhanced expression levels of full-length and trun-
cated eIF3e proteins. To con¢rm the integrity of the cDNA,
a TNT system (Promega) was employed, resulting in a protein
both of the expected size and pI (Fig. 2). Western blots of
proteins derived from the cell lines showed a band at 48 kDa
for all cell lines as expected for the endogenous eIF3e (data
not shown). However, a band representing the truncated pro-
tein (19 kDa) was not seen with the various p48T cell lines
(note: during preparation of this manuscript Rasmussen et al.
[35] also failed to observe a truncated product in stable cells
expressing Int6-short). A second attempt was made to identify
the truncated protein based on its relatively acidic pI (4.98),
but again, no band was observed. Apparently, the truncated
form is unstable and does not accumulate at any detectable
level in the cells. Alternatively, any amino-terminal modi¢ca-
tions would make the protein undetectable to the antibody,
due to the fact that the antibody was raised against a peptide
representing the 19 amino-terminal residues of eIF3e.
The phenotypic characteristics of the long-term transfected
cells were examined. Wild type NIH 3T3 cells exhibited a
doubling time of 28.2 h (Table 1), similar to data previously
reported [2]. Wild type cells showed normal contact inhibition,
no foci formation (Fig. 3A), normal morphology (Fig. 3B),
and no growth in soft agar (Fig. 3C). Wild type cells were also
not able to inhibit apoptosis, with 63% of cells being apopto-
tic after 48 h on reduced serum (Fig. 4). The p48P cell line
had a prolonged doubling time of 33.6 h, reduced con£uency
(50%) compared to wild type, no foci formation, normal mor-
phology, and no growth in soft agar. The p48P cell line was
not resistant to apoptosis, with 58% of cells being apoptotic in
the medium deprived of serum. The p48T clones all exhibited
decreased doubling times (21.9, 22.7, and 21.3 h), as well as
increased saturation densities (178%, 168%, and 209%) com-
pared to wild type cells for p48T1, p48T2 and p48TP respec-
tively. The three p48T cell lines formed foci on plates, exhib-
ited aberrant morphologies, and were able to form colonies in
soft agar. The ability to grow in soft agar often correlates with
tumorigenicity in mice. The p48TP cells were resistant to apo-
ptosis, with only 16% of cells being apoptotic after 48 h with
reduced serum.
4. Discussion
The data above indicate that truncation of eIF3e causes cell
malignancy, but the mechanism whereby this form of eIF3e
in£uences cell proliferation is not obvious. Two general pos-
sibilities can be identi¢ed: (1) eIF3e functions exclusively in
the eIF3 complex as a component of translation; and (2)
eIF3e has one or more additional functions independent
from eIF3. Considering the ¢rst possibility, the involvement
of the translational machinery is consistent with the well-de-
scribed oncogenic properties of several other initiation factors,
most notably eIF4E. In the case of eIF3, the yeast eIF3 is
comprised of ¢ve essential core proteins homologous to mam-
malian eIF3a (p170), eIF3b (p116), eIF3c (p110), eIF3g (p44),
and eIF3i (p36). This yeast core possesses the major activities
attributed to eIF3 [36]. Several other mammalian subunits,
including eIF3e and eIF3j [37], have homologous yeast pro-
teins which are not essential, yet a¡ect initiation whenever
inactivated or deleted. The ¢ve core subunits may serve as a
sca¡old for docking of other regulatory proteins. Since failure
to down-regulate translation corresponds with malignancy,
one can hypothesize that the normal function of eIF3e may
Fig. 2. Sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and isoelectric focusing (IEF) of truncated eIF3e.
Truncated eIF3e was expressed with the TNT Kit (Promega) and
[35S]methionine following the protocol provided. A: The TNT prod-
uct was examined by 15% SDS^PAGE and the gel was exposed to
X-ray ¢lm overnight. Molecular weight markers are indicated on
the left. A single major band corresponding to truncated eIF3e is
observed on the autoradiogram. B: The TNT product was run on a
pH 3.5^10 IEF gel and exposed to X-ray ¢lm overnight. IEF
markers are identi¢ed on the left and the major band corresponding
to truncated eIF3e is observed on the autoradiogram.
Table 1
Growth properties of cell lines
Cell line Doubling Time (h) Standard deviation Maximum density (U104 cells)
Wild type 3T3 28.2 2.1 335
p48P 33.6 0.5 166
p48TP 21.3 1.2 700
p48T1 21.9 2.2 595
p48T2 22.7 0.3 565
Cell lines were grown on 35 mm plates and fed every other day with DMEM containing 10% FCS. Cells were trypsinized and counted daily
with a hemocytometer. Data are from at least three experiments done in duplicate. Maximum density is the number of cells observed after no
further growth has occurred for 3 days.
FEBS 25795 11-3-02 Cyaan Magenta Geel Zwart
G.L. Mayeur, J.W.B. Hershey/FEBS Letters 514 (2002) 49^54 51
be to down-regulate eIF3 activity. This view is supported by
the observations that cells overexpressing eIF3e results in a
slower growth rate and the ¢nding that LOH of the eIF3e
(int6) locus occurs is numerous cancer cells. This assumes
that the LOH of eIF3e is the critical factor in the transforma-
tion (other genes may be a¡ected) and that LOH results in
decreased protein expression (only mRNA levels have been
examined). It is likely that the truncated form of eIF3e exhib-
its a loss of function due to the fact that about two-thirds of
the protein is missing. This inactive truncated mutant may
displace active eIF3e from the eIF3 complex, eliminating the
down-regulatory e¡ects of intact eIF3e. However, immuno-
precipitation of eIF3a from lysates of cells expressing the
truncated eIF3e showed normal amounts of full-length
eIF3e in the eIF3 complex (data not shown). If full-length
eIF3e remains bound to eIF3 it should maintain its ability
to interact with p56, a protein whose expression is induced
by interferon, and that functions to inhibit protein synthesis.
The down-regulation of protein synthesis due to the interac-
tion of eIF3e with p56 does not result from the removal of
eIF3e from the eIF3 complex [29]. eIF3e may simply act as a
docking site for p56, rather than directly regulating protein
synthesis via its interaction with p56. The free truncated eIF3e
may interfere with this interaction, preventing down-regula-
Fig. 3. Phenotypes of cell lines. Cells were grown to con£uency and maintained for 1 week with the addition of fresh media every other day.
Cells were ¢xed in 10% formaldehyde and stained with 0.1% methylene blue. B: Magni¢ed view of the same cells in column A, exhibiting the
aberrant growth of cells expressing truncated eIF3e. C: Cells were grown in soft agar as described in Section 2. Colonies were photographed
after 3 weeks.
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tion of translation. This possibility is amenable to experimen-
tal veri¢cation.
In ¢ssion yeast, cells lacking eIF3e (vInt6) have a slow
growth phenotype in minimal medium that was corrected by
expression of full-length human or yeast eIF3e or a C-termi-
nal fragment (which would be lacking in the p48T cell line),
but was not corrected by an N-terminal fragment correspond-
ing to the predicted MMTV disrupted products. The loss-of-
function hypothesis could explain the lack of correction by the
N-terminal fragment, but the slow growth phenotype of vInt6
indicates a positive regulatory role for eIF3e. The slow growth
phenotype may be a result of its function outside eIF3 com-
plex (see below). Bandyopadhyay et al. [26] showed that the
e¡ect of vInt6 on polysome pro¢les is minimal, indicating that
the negative growth e¡ect of vInt6 is not due to a global
decrease in protein synthesis.
Examining the function of eIF3e outside the eIF3 complex,
we note that eIF3e interacts with the COP9 complex inde-
pendent of its interaction with eIF3 [38]. The COP9 signal-
osome, a protein complex highly conserved between plants
and animals, may be involved in regulating protein stability
via the ubiquitin-modulated degradation pathway and may be
in the c-Jun signaling pathway (reviewed in [39]). The poten-
tial activity of truncated eIF3e in the COP9 complex has not
been addressed experimentally, although one can imagine
many mechanisms involving protein stability and signaling.
Either a loss of function or a dominant negative activity
caused by eIF3e truncation could a¡ect these pathways, re-
sulting in loss of growth control. Further research into the
function of eIF3e and its interactions with other protein com-
plexes in the cell is required for a full understanding of its
oncogenic properties.
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